SODIUM CHLORIDE MEINSOL 9 mg/ml SOLUTION FOR PARENTERAL USE

2. What you need to know before starting to use Sodium Chloride Meinsol

Do not use Sodium Chloride Meinsol:

• If you have had any allergic or unusual reaction to sodium chloride.
• If you have a high concentration of sodium in the blood (hypernatremia)
• If you have increased muscle tone (hypertonia)
• If you suffer from heart failure (inability of the heart to pump the necessary amount of blood)
• If you have any heart, liver, or kidney disorder and suffer from water accumulation (edema) in the body
• If you have severe high blood pressure (severe hypertension)
• If you have an excess of acid in the blood (metabolic acidosis)

Warnings and Precautions

Consult your doctor or pharmacist before starting to use Sodium Chloride Meinsol

• The solutions, once opened, must be used immediately.
• In the case of subcutaneous administration, do not add any supplement that may change the isotonicity of the solution.
• Do not use the solution if it is not transparent and free of precipitates.
• Ensure the physical-chemical compatibility when adding medication to the ampoule.
• The addition of alcohol to sodium chloride solutions should be avoided.

Children

Newborns may present excessively high levels of sodium due to the immaturity of their kidneys. Therefore, repeated injections of sodium chloride can only be administered to them once the sodium levels in the blood have been determined.

Sodium chloride should be used with caution in patients with hypertension, heart failure, pulmonary or peripheral edema, altered renal function, pre-eclampsia, hyperaldosteronism, cirrhosis, and other liver diseases, hypervolemia, urinary tract obstruction, hypoproteinemia, and other diseases and treatments (e.g., corticosteroids) associated with sodium retention.

Use of Sodium Chloride Meinsol with other medications:

Inform your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication.

Interactions with other medications depend on the medication added.

The 9 mg/ml sodium chloride solution presents incompatibilities with hydrocortisone, amphotericin B, tetracyclines, cephalotin, erythromycin, lactobionate, and lithium salts.

It is incompatible with active principles that are not soluble in the sodium chloride solution, due to possible precipitation of the active principle, as well as with medications whose stability or solubility require a very acidic or strongly alkaline pH.

Pregnancy and Breastfeeding:

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using a medication.

Given the characteristics of the product, no effect on pregnant or breastfeeding women is expected, provided that administration is correct and controlled.

Driving and Using Machines:

There is no indication that the isotonic sodium chloride solution may affect the ability to drive or use machines.

3. How to use Sodium Chloride Meinsol

Follow these instructions unless your doctor has given you different instructions. Sodium Chloride Meinsol is administered intravenously, intramuscularly, or subcutaneously.

It is not necessary to sterilize the ampoule before opening it.

No cutting element is needed to open the ampoule.

Once the ampoule is opened, the nozzle fits perfectly onto the cone of the syringe (Luer cone), so it is not necessary to use a needle.

To open:

To separate an ampoule from the rest, turn one ampoule on itself against the rest of the ampoules in the strip without touching the head and neck of the ampoules (1). Shake the ampoule with a single movement as shown in the drawing to eliminate any liquid that may be in the stopper (2). To open the ampoule, turn the body and head of the ampoule in opposite directions until it breaks at the neck (3). Connect the Luer or Luer-lock syringe as shown in the drawing (4).

So, no needle is needed to extract the solution. Extract the liquid.

The solution does not contain any type of preservative or bactericide, so opened and unused ampoules must be discarded immediately.

The amount to be used will vary depending on the concentration to be administered of the medication to be dissolved.

Your doctor will indicate the duration of treatment with your medication.

If you think the effect of Sodium Chloride Meinsol is too strong or weak, inform your doctor.

If you use more Sodium Chloride Meinsol than you need:

If you have received more Sodium Chloride Meinsol than you need, consult your doctor immediately.

Given the nature of the product, if its indication and administration are correct and controlled, there is no risk of intoxication.

However, an excess of sodium chloride, in its most acute form, produces dehydration of the internal organs, nausea, vomiting, diarrhea, abdominal cramps, thirst, decreased salivation and tearing, sweating, fever, hypotension, tachycardia, renal failure, pulmonary edema, acidosis, respiratory arrest, headache, dizziness, irritability, muscle spasms, stiffness, coma, and death.

In case of symptoms of intoxication, administration will be suspended, and symptomatic treatment will be resorted to.

In children, coma and convulsions can persist until vascular lesions are produced. Difficulty breathing with tachypnea and redness of the nostrils may also appear.

In case of overdose or accidental ingestion, go immediately to a medical center or call the Toxicology Information Service at 91 562 04 20.

4. Possible Adverse Effects

Like all medications, this medication can produce adverse effects, although not all people experience them.

The inadequate or excessive administration of physiological saline solution can produce hyperhydration, hypernatremia, hyperchloremia, and related manifestations, such as metabolic acidosis, due to the decrease in bicarbonate concentration, and edema formation.

An excess of sodium chloride can produce nausea, vomiting, headache.

Adverse reactions can also be related to the added medication.

Reporting Adverse Effects

If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this prospectus. You can also report them directly through the Spanish Medication Surveillance System for Human Use, http://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.

5. Storage of Sodium Chloride Meinsol

Keep this medication out of the sight and reach of children.

No special storage conditions are required.

Do not use this medication after the expiration date shown on the packaging after CAD. The expiration date is the last day of the month indicated.

Once the package is opened, the product must be used immediately.

6. Package Contents and Additional Information

• The active ingredient is Sodium Chloride. Each 100 ml contains 0.9 g of sodium chloride.
• The excipients are water for injectable preparations, hydrochloric acid, and sodium hydroxide.

Centesimal composition:

Electrolytes mmol/l mEq/l

Sodium Chloride 0.9 g Na+ 154 154

Water for injectable preparations c.s.p. 100 ml Cl- 154 154

Osmolarity: 308 mOsmol/liter.

Appearance of the Product and Package Contents

Sodium Chloride Meinsol 9 mg/ml solvent for parenteral use is a clear and colorless solution, free or practically free of particles.

Sodium Chloride Meinsol is a solvent for parenteral use that is presented in the following formats:

Box with 20 ampoules of 5 ml (Clinical Package) Box with 50 ampoules of 5 ml (Clinical Package) Box with 20 ampoules of 10 ml (Clinical Package) Box with 50 ampoules of 10 ml (Clinical Package) Box with 20 ampoules of 20 ml (Clinical Package)

Not all package sizes may be marketed.

Marketing Authorization Holder:

FRESENIUS KABI ESPAÑA, S.A.U.

C/ Marina, 16-18

08005-Barcelona (Spain)

Manufacturer:

FRESENIUS KABI ESPAÑA, S.A.U.

C/ Dr. Ferran, 12

08339 Vilassar de Dalt

Spain

This medication is authorized in the member states of the European Economic Area with the following names:

Date of the last revision of this prospectus: January 2015

Detailed and updated information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/